| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1038574619 |
| P356 | DOI | 10.1186/1742-4682-5-19 |
| P932 | PMC publication ID | 2542356 |
| P698 | PubMed publication ID | 18687151 |
| P5875 | ResearchGate publication ID | 23156003 |
| P2093 | author name string | Hirotaka Ando | |
| Ippei Nakagawa | |||
| Wataru Hori | |||
| Shigeru Izawa | |||
| P2860 | cites work | Extrapolation of diclofenac clearance from in vitro microsomal metabolism data: role of acyl glucuronidation and sequential oxidative metabolism of the acyl glucuronide | Q30747312 |
| Allometric scaling of pharmacokinetic parameters in drug discovery: can human CL, Vss and t1/2 be predicted from in-vivo rat data? | Q30940461 | ||
| Prediction of human drug clearance from in vitro and preclinical data using physiologically based and empirical approaches | Q30984976 | ||
| Mechanism-based pharmacokinetic/pharmacodynamic modeling of the electroencephalogram effects of GABAA receptor modulators: in vitro-in vivo correlations | Q34529915 | ||
| Clinical pharmacokinetics of epidural and spinal anaesthesia | Q38657879 | ||
| Role of the enterohepatic circulation in the elimination of phenytoin in the rat | Q39178820 | ||
| Prediction of the disposition of nine weakly acidic and six weakly basic drugs in humans from pharmacokinetic parameters in rats | Q39851158 | ||
| Physiological parameter values for physiologically based pharmacokinetic models | Q41556435 | ||
| The disposition of gemifloxacin, a new fluoroquinolone antibiotic, in rats and dogs. | Q43548044 | ||
| Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans. | Q43740204 | ||
| Prediction of the disposition of midazolam in surgical patients by a physiologically based pharmacokinetic model | Q43824833 | ||
| Comparative studies on in vitro methods for evaluating in vivo function of MDR1 P-glycoprotein | Q43850599 | ||
| Prediction of pharmacokinetics prior to in vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition | Q43971739 | ||
| Prediction of hepatic clearance and availability by cryopreserved human hepatocytes: an application of serum incubation method | Q44068573 | ||
| Effect of glycerol-induced acute renal failure on the pharmacokinetics of lidocaine after transdermal application in rats | Q44545881 | ||
| Reduction and lumping of physiologically based pharmacokinetic models: prediction of the disposition of fentanyl and pethidine in humans by successively simplified models | Q44676689 | ||
| Effects of cimetidine on lidocaine distribution in rats | Q45164355 | ||
| Application of a generic physiologically based pharmacokinetic model to the estimation of xenobiotic levels in human plasma | Q46750037 | ||
| Drug interactions between imipramine and benzodiazepines in rats | Q48161609 | ||
| Prediction of metabolic drug clearance in humans: in vitro-in vivo extrapolation vs allometric scaling | Q48463862 | ||
| Kinetic evaluation for measurement of in vivo receptor occupancy by psychotropic drug in brain: implication for human studies | Q48704138 | ||
| The tissue distribution, metabolism and excretion of lidocaine in rats, guinea pigs, dogs and man | Q48797060 | ||
| Physiologically based pharmacokinetics of drug-drug interaction: a study of tolbutamide-sulfonamide interaction in rats | Q48934163 | ||
| Dose-independent pharmacokinetics of intravenous lidocaine in humans. | Q51854434 | ||
| Biotransformation of [14C]midazolam in the ratin vitroandin vivo | Q51867270 | ||
| Mechanistic approaches to volume of distribution predictions: understanding the processes. | Q51919468 | ||
| Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases. | Q51975107 | ||
| Accuracy of allometrically predicted pharmacokinetic parameters in humans: role of species selection. | Q52408256 | ||
| Biliary excretion of diazepam in the rat. | Q52722114 | ||
| Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics. | Q52722509 | ||
| A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. I. Clearance. | Q52963239 | ||
| A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. II. Volume of distribution and mean residence time. | Q52963243 | ||
| Prediction of human pharmacokinetics using physiologically based modeling: a retrospective analysis of 26 clinically tested drugs. | Q53024733 | ||
| Limited distribution of new quinolone antibacterial agents into brain caused by multiple efflux transporters at the blood-brain barrier. | Q54483675 | ||
| Kinetic analysis of phenytoin disposition in rats with experimental renal and hepatic diseases | Q67935208 | ||
| Imipramine and desipramine disposition in the elderly | Q70045130 | ||
| The metabolism and excretion of [14C]imipramine in an experimental hepatitis | Q70604354 | ||
| [Absorption, distribution, excretion and metabolism of [14C] T-3761 in rats and mice] | Q71964063 | ||
| Carrier-mediated mechanism for the biliary excretion of the quinolone antibiotic grepafloxacin and its glucuronide in rats | Q74294325 | ||
| Physiologically-based pharmacokinetic analysis of grepafloxacin | Q74330428 | ||
| Application of full physiological models for pharmaceutical drug candidate selection and extrapolation of pharmacokinetics to man | Q81445372 | ||
| Modelling and simulation in prediction of human xenobiotic absorption, distribution, metabolism and excretion (ADME): in vitro-in vivo extrapolations (IVIVE) | Q81516853 | ||
| Extrapolation of preclinical pharmacokinetics and molecular feature analysis of "discovery-like" molecules to predict human pharmacokinetics | Q83169875 | ||
| A novel strategy for physiologically based predictions of human pharmacokinetics | Q83204523 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | pharmacokinetics | Q323936 |
| P304 | page(s) | 19 | |
| P577 | publication date | 2008-08-08 | |
| P1433 | published in | Theoretical Biology and Medical Modelling | Q15750144 |
| P1476 | title | Utility of a single adjusting compartment: a novel methodology for whole body physiologically-based pharmacokinetic modelling | |
| P478 | volume | 5 |
| Q51218938 | Altered tolbutamide pharmacokinetics by a decrease in hepatic expression of CYP2C6/11 in rats pretreated with 5-fluorouracil. |
| Q34034839 | An analysis of whole body tracer kinetics in dynamic PET studies with application to image-based blood input function extraction |
| Q47588877 | Assessment of a statistical AIF extraction method for dynamic PET studies with 15O water and 18F fluorodeoxyglucose in locally advanced breast cancer patients |
| Q55226306 | Correction: Utility of a single adjusting compartment: a novel methodology for whole body physiologically-based pharmacokinetic modelling. |
| Q89842080 | Model informed quantification of the feed-forward stimulation of growth hormone by growth hormone-releasing hormone |
Search more.